Paper37307481
Therapy targeting antigen-specific T cells by a peptide-based tolerizing vaccine against autoimmune arthritis.
Urbonaviciute V and 17 others. Proc Natl Acad Sci U S A, 2023. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. Therapy targeting antigen-specific T cells by a peptide-based tolerizing vaccine against autoimmune arthritis. Papers, record 37307481. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37307481
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Therapy targeting antigen-specific T cells by a peptide-based tolerizing vaccine against autoimmune arthritis.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Autoimmune Diseases | Major topic |
| Arthritis, Rheumatoid | Major topic |
| Animals | |
| Mice | |
| Vaccines, Subunit | |
| T-Lymphocytes, Regulatory | |
| Antibodies |
Source PubMed
References54
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23310951 | Multiplex analyses of antibodies against citrullinated peptides in individuals prior to development of rheumatoid arthritis. | Arthritis Rheum | 2013 | https://conductscience.org/library/papers/23310951 | PubMed |
| 2 | 11263770 | Shift toward T helper 1 cytokines by type II collagen-reactive T cells in patients with rheumatoid arthritis. | Arthritis Rheum | 2001 | https://conductscience.org/library/papers/11263770 | PubMed |
| 3 | 35027402 | Key interactions in the trimolecular complex consisting of the rheumatoid arthritis-associated DRB1*04:01 molecule, the major glycosylated collagen II peptide and the T-cell receptor. | Ann Rheum Dis | 2022 | https://conductscience.org/library/papers/35027402 | PubMed |
| 4 | 9510154 | Induction of autoimmune arthritis in HLA-DR4 (DRB1*0401) transgenic mice by immunization with human and bovine type II collagen. | J Immunol | 1998 | https://conductscience.org/library/papers/9510154 | PubMed |
| 5 | 26606968 | Type 1 diabetes immunotherapy using polyclonal regulatory T cells. | Sci Transl Med | 2015 | https://conductscience.org/library/papers/26606968 | PubMed |
| 6 | 12816990 | Recombinant TCR ligand induces tolerance to myelin oligodendrocyte glycoprotein 35-55 peptide and reverses clinical and histological signs of chronic experimental autoimmune encephalomyelitis in HLA-DR2 transgenic mice. | J Immunol | 2003 | https://conductscience.org/library/papers/12816990 | PubMed |
| 7 | 8026530 | Expression of a transgenic class II Ab gene confers susceptibility to collagen-induced arthritis. | Eur J Immunol | 1994 | https://conductscience.org/library/papers/8026530 | PubMed |
| 8 | 27009267 | Restoring oxidant signaling suppresses proarthritogenic T cell effector functions in rheumatoid arthritis. | Sci Transl Med | 2016 | https://conductscience.org/library/papers/27009267 | PubMed |
| 9 | 16723470 | Treatment of autoimmune anterior uveitis with recombinant TCR ligands. | Invest Ophthalmol Vis Sci | 2006 | https://conductscience.org/library/papers/16723470 | PubMed |
| 10 | 23576302 | Partial MHC class II constructs inhibit MIF/CD74 binding and downstream effects. | Eur J Immunol | 2013 | https://conductscience.org/library/papers/23576302 | PubMed |
| 11 | 20546940 | Binding of recombinant T cell receptor ligands (RTL) to antigen presenting cells prevents upregulation of CD11b and inhibits T cell activation and transfer of experimental autoimmune encephalomyelitis. | J Neuroimmunol | 2010 | https://conductscience.org/library/papers/20546940 | PubMed |
| 12 | 32600443 | VISTA: an immune regulatory protein checking tumor and immune cells in cancer immunotherapy. | J Hematol Oncol | 2020 | https://conductscience.org/library/papers/32600443 | PubMed |
| 13 | 20870173 | The mammalian target of rapamycin: linking T cell differentiation, function, and metabolism. | Immunity | 2010 | https://conductscience.org/library/papers/20870173 | PubMed |
| 14 | 10591176 | Toxic MHC class II beta chains. | Immunity | 1999 | https://conductscience.org/library/papers/10591176 | PubMed |
| 15 | 34249012 | Conversion of Anergic T Cells Into Foxp3- IL-10+ Regulatory T Cells by a Second Antigen Stimulus In Vivo. | Front Immunol | 2021 | https://conductscience.org/library/papers/34249012 | PubMed |
| 16 | 28012172 | MHC class II alleles associated with Th1 rather than Th17 type immunity drive the onset of early arthritis in a rat model of rheumatoid arthritis. | Eur J Immunol | 2017 | https://conductscience.org/library/papers/28012172 | PubMed |
| 17 | 15535832 | Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells. | Arthritis Res Ther | 2004 | https://conductscience.org/library/papers/15535832 | PubMed |
| 18 | 22124124 | Arthritogenic self-reactive CD4+ T cells acquire an FR4hiCD73hi anergic state in the presence of Foxp3+ regulatory T cells. | J Immunol | 2012 | https://conductscience.org/library/papers/22124124 | PubMed |
| 19 | 1378019 | Identification of an immunodominant type-II collagen peptide recognized by T cells in H-2q mice: self tolerance at the level of determinant selection. | Eur J Immunol | 1992 | https://conductscience.org/library/papers/1378019 | PubMed |
| 20 | 16785524 | Lymphotoxin pathway-directed, autoimmune regulator-independent central tolerance to arthritogenic collagen. | J Immunol | 2006 | https://conductscience.org/library/papers/16785524 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41451511 | Nanoparticle-Based Tolerogenic Vaccines: Next-Generation Strategies for Autoimmune and Allergic Disease Therapies. | Angew Chem Int Ed Engl | 2026 | https://conductscience.org/library/papers/41451511 | PubMed |
| 41012116 | Possible Anti-Pain Vaccines: A Narrative Review of Emerging Strategies and Clinical Prospects. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/41012116 | PubMed |
| 40730179 | Vaccine therapy for rheumatoid arthritis: A step forward. | Mol Ther | 2025 | https://conductscience.org/library/papers/40730179 | PubMed |
| 40696875 | Self-Antigens Select B Cells: A New Perspective on B Cell Selection and Function. | Eur J Immunol | 2025 | https://conductscience.org/library/papers/40696875 | PubMed |
| 40285352 | Tolerogenic antigen-specific vaccine induces VISTA-enriched regulatory T cells and protects against arthritis in DRB1∗04:01 mice. | Mol Ther | 2025 | https://conductscience.org/library/papers/40285352 | PubMed |
| 39921498 | A Spleen-Targeted Tolerogenic mRNA-LNPs Vaccine for the Treatment of Experimental Asthma. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/39921498 | PubMed |
| 39596089 | Targeted Therapy of Antibody-Induced Autoimmune Arthritis Using Peptide-Guided Nanoparticles. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39596089 | PubMed |
| 39376556 | Overview of mechanisms and novel therapies on rheumatoid arthritis from a cellular perspective. | Front Immunol | 2024 | https://conductscience.org/library/papers/39376556 | PubMed |
| 39362875 | Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders. | Signal Transduct Target Ther | 2024 | https://conductscience.org/library/papers/39362875 | PubMed |
| 38903522 | Editorial: Exploring the role of T helper cells in autoimmune disease. | Front Immunol | 2024 | https://conductscience.org/library/papers/38903522 | PubMed |
| 38602454 | Human MHC Class II and Invariant Chain Knock-in Mice Mimic Rheumatoid Arthritis with Allele Restriction in Immune Response and Arthritis Association. | Adv Sci (Weinh) | 2024 | https://conductscience.org/library/papers/38602454 | PubMed |
Genes11
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| APC | 324 | PubTator's text mining | https://conductscience.org/library/genes/324 | NCBI Gene |
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CLIP1 | 6249 | PubTator's text mining | https://conductscience.org/library/genes/6249 | NCBI Gene |
| HLA-DRB1 | 3123 | PubTator's text mining | https://conductscience.org/library/genes/3123 | NCBI Gene |
| HLA-DRB4 | 3126 | PubTator's text mining | https://conductscience.org/library/genes/3126 | NCBI Gene |
| IL2 | 3558 | PubTator's text mining | https://conductscience.org/library/genes/3558 | NCBI Gene |
| LAG3 | 3902 | PubTator's text mining | https://conductscience.org/library/genes/3902 | NCBI Gene |
| NT5E | 4907 | PubTator's text mining | https://conductscience.org/library/genes/4907 | NCBI Gene |
| SLC26A3 | 1811 | PubTator's text mining | https://conductscience.org/library/genes/1811 | NCBI Gene |
| TBCA | 6902 | PubTator's text mining | https://conductscience.org/library/genes/6902 | NCBI Gene |
| TRBV20OR9-2 | 6962 | PubTator's text mining | https://conductscience.org/library/genes/6962 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37307481
GET https://conductscience.org/api/papers/v1/37307481/references?page=2